Intended Use

Software platform indicated for cancer patients prescribed radiotherapy treatment, providing AI-based segmentation of organs at risk, lymph nodes, tumors and automatic radiotherapy treatment plan generation imported into local TPS systems for dose calculation and approval.

Technology

AI-based deep learning segmentation for multiple anatomical regions on CT and MR images; automatic treatment plan generation imported into external TPS; supports batch processing integration into radiotherapy workflow.

Performance

Extensive non-clinical validation for auto-segmentation and treatment planning including comparison to manual contours by experts using DSC metrics, qualitative clinician assessments, inter-expert variability checks, and quantitative validation on multiple patient datasets; acceptance criteria consistently met for clinical use; treatment plans evaluated quantitatively and qualitatively with high clinical acceptability rates.

Predicate Devices

No predicate devices specified

Ready to Sharpen Your Edge?

Subscribe to join 7,600+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.